There’s emerging evidence that the allergy drug omalizumab may reduce severe allergic reactions for alpha-gal syndrome, a red meat allergy triggered by a tick bite. There’s emerging evidence that the allergy drug omalizumab may reduce severe allergic reactions for alpha-gal syndrome, a red meat allergy triggered by a tick bite.
For alpha-gal patients, allergy drug could cut the severity of reactions to red meatFor alpha-gal patients, allergy drug could cut the severity of reactions to red meat

